Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2024

Open Access 01-12-2024 | Research

Predictors for new-onset conduction block in patients with pure native aortic regurgitation after transcatheter aortic valve replacement with a new-generation self-expanding valve (VitaFlow Liberty): a retrospective cohort study

Authors: Xuan Zhang, Cheng Liang, Lintao Zha, Quan Zuo, Guobing Hu, Jie Ding, Shengxing Tang

Published in: BMC Cardiovascular Disorders | Issue 1/2024

Login to get access

Abstract

Background

New-generation self-expanding valves can improve the success rate of transcatheter aortic valve replacement (TAVR) for severe pure native aortic regurgitation (PNAR). However, predictors of new-onset conduction block post-TAVR using new-generation self-expanding valves in patients with PNAR remain to be established. Therefore, this study aimed to identify predictors of new-onset conduction block post-TAVR using new-generation self-expanding valves (VitaFlow Liberty™) in patients with PNAR.

Methods

In this retrospective cohort study, patients were categorized into pacemaker and non-pacemaker groups based on their need for new postoperative permanent pacemaker implantation (PPI). Based on the postoperative presence of either new-onset complete left bundle branch block (cLBBB) or high-grade atrioventricular block (AVB), patients were further classified into conduction disorder and non-conduction disorder groups. Laboratory, echocardiographic, computed tomography, preoperative and postoperative electrocardiography, and procedural and clinical data were collected immediately after TAVR and during hospitalization and compared between the groups. Multivariate logistic regression analysis was performed incorporating the significant variables from the univariate analyses.

Results

This study examined 68 consecutive patients with severe PNAR who underwent TAVR. In 20 patients, a permanent pacemaker was fitted postoperatively. Multivariate logistic regression analysis revealed an association between the need for postoperative PPI and preoperative complete right bundle branch block (cRBBB) or first-degree AVB, as well as a non-tubular left ventricular outflow tract (LVOT). In addition, valve implantation depth and angle of aortic root were independent predictors of new-onset cLBBB or high-grade AVB developing post-TAVR. The predictive value of valve implantation depth and angle of aortic root was further supported by receiver operating characteristic curve analysis results.

Conclusions

In patients with PNAR undergoing TAVR using self-expanding valves, preoperative cRBBB or first-degree AVB and a non-tubular LVOT were indicators of a higher likelihood of PPI requirement. Moreover, deeper valve implantation depth and greater angle of aortic root may be independent risk factors for new-onset cLBBB or high-grade AVB post-TAVR. Valve implantation depth and angle of aortic root values may be used to predict the possibility of new cLBBB or high-grade AVB post-TAVR.
Appendix
Available only for authorised users
Literature
1.
go back to reference Vahanian ATFM, Alfieri A, Andreotti O, Antunes F, Barón-Esquivias MJ, Baumgartner G. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-thoracic surgery (EACTS). Eur Heart J. 2012;33:2451–96. https://doi.org/10.1093/eurheartj/ehs109.CrossRefPubMed Vahanian ATFM, Alfieri A, Andreotti O, Antunes F, Barón-Esquivias MJ, Baumgartner G. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-thoracic surgery (EACTS). Eur Heart J. 2012;33:2451–96. https://​doi.​org/​10.​1093/​eurheartj/​ehs109.CrossRefPubMed
5.
go back to reference Members WC, Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP III, et al. ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. J Am Coll Cardiol. 2021;77:e25–e197. https://doi.org/10.1016/j.jacc.2020.11.018.CrossRef Members WC, Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP III, et al. ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. J Am Coll Cardiol. 2021;77:e25–e197. https://​doi.​org/​10.​1016/​j.​jacc.​2020.​11.​018.CrossRef
14.
go back to reference Sawaya FJ, Deutsch MA, Seiffert M, Yoon SH, Codner P, Wickramarachchi U, et al. Safety and efficacy of transcatheter aortic valve replacement in the treatment of pure aortic regurgitation in native valves and failing surgical bioprostheses: results from an international registry study. JACC Cardiovasc Interv. 2017;10:1048–56. https://doi.org/10.1016/j.jcin.2017.03.004.CrossRefPubMed Sawaya FJ, Deutsch MA, Seiffert M, Yoon SH, Codner P, Wickramarachchi U, et al. Safety and efficacy of transcatheter aortic valve replacement in the treatment of pure aortic regurgitation in native valves and failing surgical bioprostheses: results from an international registry study. JACC Cardiovasc Interv. 2017;10:1048–56. https://​doi.​org/​10.​1016/​j.​jcin.​2017.​03.​004.CrossRefPubMed
26.
go back to reference Chen S, Zheng F, Li M, Hou S, Zhang W, Zhang L, et al. A study on correlation between preprocedural CT indexes and procedural success rate of transfemoral transcatheter aortic valve replacement with different self-expanding valves (VitaFlow or VenusA-Valve) in patients with pure native aortic regurgitation. Ann Transl Med. 2022;10:643. https://doi.org/10.21037/atm-22-2588.CrossRefPubMedPubMedCentral Chen S, Zheng F, Li M, Hou S, Zhang W, Zhang L, et al. A study on correlation between preprocedural CT indexes and procedural success rate of transfemoral transcatheter aortic valve replacement with different self-expanding valves (VitaFlow or VenusA-Valve) in patients with pure native aortic regurgitation. Ann Transl Med. 2022;10:643. https://​doi.​org/​10.​21037/​atm-22-2588.CrossRefPubMedPubMedCentral
29.
go back to reference Wang R, Kawashima H, Gao C, Mou F, Li P, Zhang J, et al. Comparative quantitative aortographic assessment of regurgitation in patients treated with VitaFlow transcatheter heart valve vs. other self-expanding systems. Front Cardiovasc Med. 2022;8. https://doi.org/10.3389/fcvm.2021.747174. Wang R, Kawashima H, Gao C, Mou F, Li P, Zhang J, et al. Comparative quantitative aortographic assessment of regurgitation in patients treated with VitaFlow transcatheter heart valve vs. other self-expanding systems. Front Cardiovasc Med. 2022;8. https://​doi.​org/​10.​3389/​fcvm.​2021.​747174.
32.
go back to reference Yao J, Lu Z-N, Modine T, Jilaihawi H, Piazza N, Tang Y-D, et al. Evaluation of the safety and efficacy of a novel anatomical classification and dUal anchoRing theory to optimize the tavR strategy for pure severe aortic regurgitation (AURORA): a prospective cohort study. BMC Cardiovasc Disord. 2022;22:1–10. https://doi.org/10.1186/s12872-022-02883-4.CrossRef Yao J, Lu Z-N, Modine T, Jilaihawi H, Piazza N, Tang Y-D, et al. Evaluation of the safety and efficacy of a novel anatomical classification and dUal anchoRing theory to optimize the tavR strategy for pure severe aortic regurgitation (AURORA): a prospective cohort study. BMC Cardiovasc Disord. 2022;22:1–10. https://​doi.​org/​10.​1186/​s12872-022-02883-4.CrossRef
Metadata
Title
Predictors for new-onset conduction block in patients with pure native aortic regurgitation after transcatheter aortic valve replacement with a new-generation self-expanding valve (VitaFlow Liberty™): a retrospective cohort study
Authors
Xuan Zhang
Cheng Liang
Lintao Zha
Quan Zuo
Guobing Hu
Jie Ding
Shengxing Tang
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2024
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-024-03735-z

Other articles of this Issue 1/2024

BMC Cardiovascular Disorders 1/2024 Go to the issue